Get the Stockscreener App
3.39
7.12%
-0.26
Health Catalyst Inc stock is traded at $3.39, with a volume of 985.70K.
It is down -7.12% in the last 24 hours and down -13.52% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$3.65
Open:
$3.64
24h Volume:
985.70K
Relative Volume:
1.36
Market Cap:
$238.57M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-2.26
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
+3.35%
1M Performance:
-13.52%
6M Performance:
-22.78%
1Y Performance:
-51.01%
1-Day Range:
$3.29
$3.66
1-Week Range:
$3.185
$3.80
52-Week Range:
$2.515
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
3.39 | 256.86M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
269.20 | 44.50B | 2.97B | 809.93M | 1.35B | 4.87 |
|
TEM
Tempus Ai Inc
|
75.86 | 12.80B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.94 | 12.81B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.33 | 7.63B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.88 | 6.67B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
How to forecast Health Catalyst Inc. trends using time seriesJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - Newser
How high can Health Catalyst Inc. stock go2025 Volatility Report & Stock Portfolio Risk Control - Newser
How to track smart money flows in Health Catalyst Inc.Portfolio Value Report & Low Drawdown Momentum Ideas - Newser
When is the best time to exit Health Catalyst Inc.Gap Down & Weekly High Return Forecasts - Newser
Is now a turning point for Health Catalyst Inc.Trade Volume Report & Daily Technical Stock Forecast Reports - Newser
Health Catalyst Inc. stock chart pattern explainedMarket Performance Report & Fast Gain Stock Trading Tips - Newser
Is Health Catalyst Inc. trending in predictive chart modelsJuly 2025 Weekly Recap & Fast Exit/Entry Strategy Plans - Newser
Using flow based indicators on Health Catalyst Inc.2025 Geopolitical Influence & Risk Controlled Daily Trade Plans - Newser
Is Health Catalyst Inc. a candidate for recovery playEntry Point & Verified Short-Term Plans - Newser
Does Health Catalyst Inc. show high probability of rebound2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Real time breakdown of Health Catalyst Inc. stock performance2025 Market Sentiment & Safe Entry Trade Reports - Newser
Will Health Catalyst Inc. rebound enough to break evenJuly 2025 Highlights & Smart Swing Trading Alerts - Newser
Can Health Catalyst Inc. withstand a market correctionJuly 2025 Trade Ideas & Expert Approved Momentum Trade Ideas - sundaytimes.kr
How hedge fund analytics apply to Health Catalyst Inc. stockPortfolio Risk Report & Safe Entry Zone Tips - Newser
What MACD signals say about Health Catalyst Inc.Weekly Profit Report & AI Forecast Swing Trade Picks - Newser
Market reaction to Health Catalyst Inc.’s recent news2025 EndofYear Setup & Low Risk High Reward Ideas - Newser
Exit strategy if you’re trapped in Health Catalyst Inc.Market Weekly Review & AI Powered Buy/Sell Recommendations - Newser
Earnings visualization tools for Health Catalyst Inc.2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser
What Fibonacci levels say about Health Catalyst Inc. rebound2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
Is Health Catalyst Inc. Forming a Consolidation Base getLinesFromResByArray error: size == 0 - newsyoung.net
Top chart patterns to watch in Health Catalyst Inc.July 2025 Sentiment & Stock Portfolio Risk Management - Newser
Predicting Health Catalyst Inc. trend using moving averagesRisk Management & Smart Swing Trading Techniques - Newser
How to interpret RSI for Health Catalyst Inc. stockWeekly Trade Review & High Win Rate Trade Alerts - Newser
Will a bounce in Health Catalyst Inc. offer an exit2025 Big Picture & Advanced Swing Trade Entry Plans - Newser
Can Health Catalyst Inc. recover in the next quarterAnalyst Upgrade & Stepwise Trade Execution Plans - Newser
Health Catalyst’s Strategic Innovation and Employee-Centric Culture: A Dual Catalyst for Sustainable Growth in 2025 - AInvest
Health Catalyst Announces Winners of the 2025 Catalyst Awards - 富途牛牛
Health Catalyst stock price target lowered to $5 at Canaccord on growth concerns - Investing.com
Analyzing recovery setups for Health Catalyst Inc. investors2025 Retail Activity & Technical Buy Zone Confirmations - Newser
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.73%
5.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):